Letters Congestive heart failure

Author’s reply

BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c4282 (Published 10 August 2010) Cite this as: BMJ 2010;341:c4282
  1. Bruce Arroll, professor and head
  1. 1Department of General Practice and Primary Health Care, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
  1. b.arroll{at}auckland.ac.nz

    We did mention candesartan in table 2, although we did not specifically reference the CHARM studies.1 2 Our focus was on the generalist physician and GP, and in primary care and cardiological care evidence shows that angiotensin converting enzyme (ACE) inhibitors and β blockers are not being initiated or titrated to maximal doses. …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe